Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

978 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group.
Ryan G, Martinelli G, Kuper-Hommel M, Tsang R, Pruneri G, Yuen K, Roos D, Lennard A, Devizzi L, Crabb S, Hossfeld D, Pratt G, Dell'Olio M, Choo SP, Bociek RG, Radford J, Lade S, Gianni AM, Zucca E, Cavalli F, Seymour JF; International Extranodal Lymphoma Study Group. Ryan G, et al. Among authors: roos d. Ann Oncol. 2008 Feb;19(2):233-41. doi: 10.1093/annonc/mdm471. Epub 2007 Oct 11. Ann Oncol. 2008. PMID: 17932394 Free article.
Radiotherapy for early infradiaphragmatic Hodgkin's disease: the Australasian experience.
Barton M, Boyages J, Crennan E, Davis S, Fisher RJ, Hook C, Johnson N, Joseph D, Khoo V, Liew KH, Morgan G, O'Brien P, Pendlebury S, Pratt G, Quong G, Roos DE, Thornton D, Trotter G, Walker Q, Wallington M. Barton M, et al. Among authors: roos de. Radiother Oncol. 1996 Apr;39(1):1-7. doi: 10.1016/0167-8140(96)01715-x. Radiother Oncol. 1996. PMID: 8735487
Combined-modality therapy for primary central nervous system lymphoma: long-term data from a Phase II multicenter study (Trans-Tasman Radiation Oncology Group).
O'Brien PC, Roos DE, Pratt G, Liew KH, Barton MB, Poulsen MG, Olver IN, Trotter GE; Trans-Tasman Radiation Oncology Group. O'Brien PC, et al. Int J Radiat Oncol Biol Phys. 2006 Feb 1;64(2):408-13. doi: 10.1016/j.ijrobp.2005.07.958. Epub 2005 Sep 28. Int J Radiat Oncol Biol Phys. 2006. PMID: 16198065 Clinical Trial.
Optimal scheduling to reduce morbidity of involved field radiotherapy with transplantation for lymphomas: a prospective Australasian Leukaemia and Lymphoma Group Study.
Wirth A, Prince HM, Wolf M, Stone JM, Matthews J, Gibson J, Macleod C, Szer J, Grigg A, To B, Roos D, Schwarer AP, Davis S; Australasian Leukaemia and Lymphoma Group. Wirth A, et al. Among authors: roos d. Bone Marrow Transplant. 2005 Feb;35(3):291-8. doi: 10.1038/sj.bmt.1704759. Bone Marrow Transplant. 2005. PMID: 15558040 Clinical Trial.
Quality indicators for early stage Hodgkin's lymphoma.
Roos DE, Tee HC. Roos DE, et al. J Med Imaging Radiat Oncol. 2017 Aug;61(4):550-556. doi: 10.1111/1754-9485.12602. Epub 2017 Mar 27. J Med Imaging Radiat Oncol. 2017. PMID: 28345307
Prognostic factors for survival and ambulatory status at 8 weeks with metastatic spinal cord compression in the SCORAD randomised trial.
Hoskin PJ, Hopkins K, Misra V, Holt T, McMenemin R, McKinna F, Madhavan K, Bates A, O'Rourke N, Lester JF, Sevitt T, Roos D, Brown G, Thomas SS, Forsyth S, Reczko K, Hackshaw A, O'Hara C, Lopes A. Hoskin PJ, et al. Among authors: roos d. Radiother Oncol. 2022 Aug;173:77-83. doi: 10.1016/j.radonc.2022.05.017. Epub 2022 May 23. Radiother Oncol. 2022. PMID: 35618101 Clinical Trial.
Adult medulloblastoma in an Australian population.
Parakh S, Davies A, Westcott K, Roos D, Abou-Hamden A, Ahern E, Lau PKH, Cheruvu S, Pranavan G, Pullar A, Lynam J, Gzell C, Whittle JR, Cain S, Inglis PL, Harrup R, Anazodo A, Hovey E, Cher L, Gan HK. Parakh S, et al. Among authors: roos d. J Clin Neurosci. 2022 Aug;102:65-70. doi: 10.1016/j.jocn.2022.06.008. Epub 2022 Jun 18. J Clin Neurosci. 2022. PMID: 35728397
978 results